Clinical implications of gemcitabine in the treatment of cervical cancer

European Journal of Cancer, Supplement

Volumn 5, Issue 1, 2007, Pages 37-43

  Candelaria, Myrna ^a   Cetina, Lucely ^a   de la Garza, Jaime ^a   Dueñas Gonzálz, Alfonso ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cervical carcinoma; Cisplatin; Combination chemotherapy; Gemcitabine; Locally advanced disease; Recurrent disease

Indexed keywords

CISPLATIN; GEMCITABINE; OXALIPLATIN; TOPOTECAN;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DRUG DOSE ESCALATION; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER;

EID: 34248519436     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6349(07)70014-9     Document Type: Article

References (49)

1. Parkin D., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Moore D. Cervical cancer. Obstet Gynecol 107 (2006) 1152-1161
3. Bonomi P., Blessing J., Sthelman F., DiSaia P., Walton L., and Major F. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecology Oncology Group Study. J Clin Oncol 3 (1985) 1079-1085
4. Long III H., Bundy B., Grendys Jr. E., et al., Gynecologic Oncology Group Study. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix:a Gynecologic Oncology Group Study. J Clin Oncol 23 (2005) 4626-4633
5. Grunewald R., Kantarjian H., Du M., Faucher K., Tarassoff P., and Plunkett W. Gemcitabine in leukemia:a Phase I clinical, plasma, and cellular pharmacology study. J Clin Oncol 12 (1994) 406-413
6. Csoka K., Liliemark J., Larsson R., and Nygren P. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumour cells from patients with hematologic or solid tumours. Semin Oncol 22 (1995) 47-53
7. Merriman R., Hertel L., Schultz R., et al. Comparison of the antitumour activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenografts models. Invest New Drugs 14 (1996) 243-247
8. Hui Y., and Reitz J. Gemcitabine:a cytidine analogue active against solid tumors. Am J Health Syst Pharm 54 (1997) 62-70
9. Hernandez P., Olivera P., Dueñas-González A., et al. Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol 48 (2001) 488-492
10. Fukuoka M., Noda K., Hasegawa K., et al. An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II. Gan To Kagaku Ryoho 23 (1996) 1813-1824
11. Schilder R., Blessing J., Morgan M., Mangan C., and Rader J. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix:a Phase II study of the gynecologic oncology group. Gynecol Oncol 76 (2000) 204-207
12. Greggi S., D'Agostino G., Smaniotto D., Genovesi D., Lorusso D., and Scambia G. Gemcitabine is ineffective in recurrent, pre-irradiated cervical cancer. Gynecol Oncol 78 (2000) 76-77
13. Goedhals L., and Bezwoda W. A phase II study of gemcitabine in advanced cervix carcinoma: final data. Proc Am Soc Clin Oncol 14 (1995) 819
14. Peters G., Bergman A., Ruin van Haperen V., Veerman G., Kuiper C., and Braakhuis G. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 22 (1995) 72
15. Matulonis U., Campos S., Duska L., et al. Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. Gynecol Oncol 103 (2006) 160-164
16. Burnett A., Roman L., Garcia A., Muderspach L., Brader K., and Morrow C. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 76 (2000) 63-66
17. Lorvidhaya V., Kamnerdsupaphon P., Chitapanarux I., Sukthomya V., and Tonusin A. Cisplatin and gemcitabine in patients with metastatic cervical cancer. Gan To Kagaku Ryoho 31 (2004) 1057-1062
18. Bouzid K., and Mahfouf H. A phase II study of gemcitabine (G) and cisplatin (C) combination in the treatment of recurrent cervical squamous cell carcinoma (RCSCC). Proc Am Soc Clin Oncol (2003) 22 [abstract 1900]
19. Brewer C., Blessing J., Nagourney R., McMeekin D., Lele S., and Zweizig S. Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix:a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 100 (2006) 385-388
20. Dueñas-González A., Hinojosa-Garcia L., Lopez-Graniel C., Melendez-Zagla J., Maldonado V., and sde la Guerra J. Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma. Am J Clin Oncol 24 (2001) 201-203
21. Benedet J., Odicino F., Maisonneuve P., et al. Annual report on the results of treatment in gynaecological cancer. J Epidemiol Biostat 3 (1998) 5-34
22. National Institutes of Health Consensus Development Conference statement on cervical cancer. Gynecol Oncol 66 (1997) 351-361
23. Green J., Kirwan J., and Tierney J. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix:a systematic review and meta-analysis. Lancet 358 (2001) 781-786
24. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005, CD002225.
25. Miglietta L., Franzone P., Centurioni M., et al. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer. Oncology 70 (2006) 19-24
26. Rose P., Bundy B., Watkins E., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
27. Tan L., Russell S., and Burgess L. Acute toxicity of chemo-radiotherapy for cervical cancer:the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 16 (2004) 255-260
28. Cetina L., Rivera L., Hinojosa J., et al. Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results. BMC Women's Health 6 (2006) 3
29. Ozsaran Z., Yalman D., Yurut V., et al. Radiochemotherapy for patients with locally advanced cervical cancer:early results. Eur J Gynaecol Oncol 24 (2003) 191-194
30. Lawrence T., Eisbruch A., and Shewach D. Gemcitabine-mediated radiosensitization. Semin Oncol 24 (1997) 24-28
31. Mose S., Karapetian M., and Juling-Pohlit L. The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine. Strahlenther Onkol 175 (1999) 78-83
32. McCormack M., and Thomas H. A phase Ib study of gemcitabine (GEM) and concurrent radiotherapy (RT) in carcinoma of the cervix. Ann Oncol 11 (2000) 88-89
33. Pattaranutaporn P., Thirapakawong C., Chansilpa Y., Thersakvivhya S., Ieumwananontachai N., and Thephamongkhol K. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. Gynecol Oncol 81 (2001) 404-407
34. Boualga K., Aksil N., Ayad M., Hasnaoui N., and Moussaoui D. Phase I/II study of gemcitabine (GEM) and concomitant radiotherapy (RT) in locally advanced carcinoma of the cervix (LACC). Proc Am Soc Clin Oncol 23 (2005) 542
35. Cetina L., Rivera L., Candelaria M., de la Garza J., and Dueñas-González A. Chemoradiation with gemcitabine for cervical cancer in patients with renal failure. Anticancer Drugs 15 (2004) 761-766
36. Alvarez A., Mickiewicz E., Roth B., et al. Feasibility of accelerated radiotherapy (Rt) concurrent with low dose biweekly gemcitabine (G) and cisplatin (C) in locally advanced cervical carcinoma (LACC). Proc Am Soc Clin Oncol 20 (2001) 100
37. Alvarez A., Rodger J., Cinat G., et al. Fifty months follow-up in patients with locally advanced cervical carcinoma (LACC) treated with low dose bi-weekly (ldbw) gemcitabine and cisplatin plus concurrent accelerated radiotherapy (AR). Proc Am Soc Clin Oncol 23 Suppl 1 (2005) 5074
38. Zarba J., Jaremtchuk A., Gonzalez Jazey P., et al. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. Ann Oncol 14 (2003) 1285-1290
39. Candelaria M., Chanona-Vilchis J., Cetina L., et al. Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol 3 (2006) 3
40. Dueñas-González A., Cetina-Perez L., Lopez-Graniel C., et al. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer:a randomized Phase II study. Int J Radiat Oncol Biol Phys 61 (2005) 817-823
41. Umanzor J., Aguiluz M., Pineda C., et al. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: A phase II trial. Gynecol Oncol 100 (2006) 70-75
42. Swisher E., Swensen R., Greer B., et al. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A phase I trial of the Puget Sound Oncology Consortium. Gynecol Oncol 101 (2006) 429-435
43. Tierney J., and Stewart L. Neoadjuvant chemotherapy followed by radiotherapy for locally advanced cervix cancer:a meta-analysis using individual patient data from randomised controlled trials. Proc ASCO 21 (2002) 207a [abstract 824]
44. Stewart L., and Tiernay J. Neoadjuvant chemotherapy and surgery versus standard radiotherapy for locally advanced cervical cancer:a meta-analysis using individual patient data from randomised controlled trials. Proc ASCO 21 (2002) 207a [abstract 825]
45. Eddy G. Neoadjuvant chemotherapy before surgery in cervical cancer. Monogr NCI 21 (1996) 93-96
46. Dueñas-González A., Lopez-Graniel C., González A., et al. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Ann Oncol 12 (2001) 541-547
47. Dueñas-González A., Lopez-Graniel C., González A., et al. Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. Am J Clin Oncol 26 (2003) 22-25
48. Termrungruanglert W., Tresukosol D., Vasuratna A., Sittisomwong T., Lertkhachonsuk R., and Sirisabya N. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. Gynecol Oncol 97 (2005) 576-581
49. Dueñas-González A., Lopez-Graniel C., Gonzalez-Enciso A., et al. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma:results from two consecutive phase II studies. Ann Oncol 13 (2002) 1212-1219